Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Meyer M, Samama"'
Autor:
Meyer M Samama, Hau C. Kwaan
Publikováno v:
Expert Review of Cardiovascular Therapy. 2:511-522
Thromboembolic disorders continue to be a major cause of morbidity and mortality, resulting in an increased need for anticoagulant therapy. In recent years, new anticoagulant drugs have been developed at a rapid pace, prompted by the recognition of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fdde87a5385eb4f54aed0b3b0c0c9be
https://doi.org/10.1586/14779072.2.4.511
https://doi.org/10.1586/14779072.2.4.511
Autor:
Meyer M. Samama, Andrew K. Vine
Publikováno v:
Seminars in Cerebrovascular Diseases and Stroke. 2:134-142
An increasing number of studies have examined the role of prothrombotic states in retinal vascular occlusions. Large case-controlled studies have revealed a cardiovascular risk profile for retinal venous occlusions. Considerable evidence implicates a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34ad3a1ae5f813374d8eecd8a2fc9d23
https://doi.org/10.1053/scds.2002.124189
https://doi.org/10.1053/scds.2002.124189
Autor:
Françoise Lelong, Anne Chabanel, Agnès Glacet-Bernard, Ali Zourdani, Gabriel Coscas, Meyer M. Samama
Publikováno v:
Ophthalmology. 103:551-560
Background: The prognosis of retinal vein occlusion is highly unpredictable because nonischemic types may convert into ischemic types within the first months. This study was designed to identify epidemiologic characteristics of the different types of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::709d46fa8c586acbdc4567a0b7a341e7
https://doi.org/10.1016/s0161-6420(96)30653-2
https://doi.org/10.1016/s0161-6420(96)30653-2
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 4
Background: Ambulatory status is often considered a criterion for stopping prophylaxis for venous thromboembolism (VTE) in medically ill patients. Methods: A subgroup analysis of the Prophylaxis in Medical Patients with Enoxaparin (MEDENOX) trial was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ecfc75a9ab602ed8e8c59ddb6490bb2
https://doi.org/10.1161/circoutcomes.4.suppl_1.ap230
https://doi.org/10.1161/circoutcomes.4.suppl_1.ap230
Autor:
Andrew K. Vine, Meyer M. Samama
Publikováno v:
Survey of Ophthalmology. 37:283-292
The hemostatic mechanisms involve both an anticoagulant system to check the coagulation cascade and a fibrinolytic system to remove formed fibrin clots. Abnormalities of the hemostatic system or acquired abnormal hematological factors can produce a t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b692096132be579fb61efd00071f06b7
https://doi.org/10.1016/0039-6257(93)90011-u
https://doi.org/10.1016/0039-6257(93)90011-u
Publikováno v:
Chest. 133
This chapter focuses on new antithrombotic drugs that are in phase II or III clinical testing. Development of these new agents was prompted by limitations of existing antiplatelet, anticoagulant, or fibrinolytic drugs. Addressing these unmet needs, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba47bf2e40672a2dcc36104a2a56762d
https://pubmed.ncbi.nlm.nih.gov/18574267
https://pubmed.ncbi.nlm.nih.gov/18574267
Autor:
Jack, Hirsh, Kenneth A, Bauer, Maria B, Donati, Michael, Gould, Meyer M, Samama, Jeffrey I, Weitz
Publikováno v:
Chest. 133
This chapter describes the pharmacology of approved parenteral anticoagulants, including the indirect anticoagulants, unfractionated heparin (UFH), low-molecular-weight heparins (LMWHs), fondaparinux, and danaparoid as well as the direct thrombin inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c6d247c99c11f692ea5344da2263d74a
https://pubmed.ncbi.nlm.nih.gov/18756611
https://pubmed.ncbi.nlm.nih.gov/18756611
Autor:
Agnégs Glacet-Bernard, Alain Taccoen, Meyer M. Samama, Anne Chabanel, Françloise Lelong, Gabriel Coscas
Publikováno v:
British Journal of Haematology. 75:127-131
Summary Reversible aggregation of red blood cells (RBC) plays an important role in determining the flow properties of blood, and is the cause of the increase in blood viscosity at low shear rates. Retinal venous circulation is characterized by the co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98bee1ef814580f9461ded2264758db0
https://doi.org/10.1111/j.1365-2141.1990.tb02628.x
https://doi.org/10.1111/j.1365-2141.1990.tb02628.x
Publikováno v:
Chest. 126
This article about new anticoagulant drugs is part of the seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines. The limitations of existing oral and parenteral anticoagulant age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f2d2f0ef6f895c60a498d39ca1cc224d
https://pubmed.ncbi.nlm.nih.gov/15383475
https://pubmed.ncbi.nlm.nih.gov/15383475
Publikováno v:
La Revue du praticien. 53(1)
Large epidemiological studies have shown that nearly all risk factors for deep vein thromboses have a different impact on the manifestation of the disease, which aids in their differentiation into high, moderate and low risk. North American authors h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f59acfd2905d232340008af53acd4676
https://pubmed.ncbi.nlm.nih.gov/12673925
https://pubmed.ncbi.nlm.nih.gov/12673925